Vaneck Vectors Pharmaceutical etf shares owned by GSA Capital Partners
Quarter-by-quarter ownership of Vaneck Vectors Pharmaceutical etf (PPH) shares owned by GSA Capital Partners
from 13F filings
Historical chart of GSA Capital Partners investment in Vaneck Vectors Pharmaceutical etf
Tip: Access up to 7 years of quarterly data
All positions including Vaneck Vectors Pharmaceutical etf held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Vaneck Vectors Pharmaceutical etf by GSA Capital Partners
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $712k | 7.9k | 90.32 |
| 2025-06-30 | $221k | 2.5k | 88.05 |
| 2025-03-31 | $260k | 2.9k | 91.20 |
| 2024-12-31 | $266k | 3.1k | 86.31 |
| 2024-06-30 | $1.2M | 13k | 91.47 |
| 2024-03-31 | $1.7M | 19k | 90.71 |
| 2023-12-31 | $803k | 9.9k | 81.40 |
| 2023-09-30 | $1.1M | 13k | 79.86 |
| 2023-06-30 | $924k | 12k | 78.77 |
| 2023-03-31 | $687k | 8.8k | 77.68 |
Top funds holding Vaneck Vectors Pharmaceutical etf
View all funds holding Vaneck Vectors Pharmaceutical etf